Search Within
Document Type
FGFR1 oncogene partner
Applied Filters:
Keyword:'FGFR1 oncogene partner'
Showing 1-6 of 6 results for "FGFR1 oncogene partner" within Technical Documents
Product Information Sheet - HPFM2
complementation group C 2176
FANCG Fanconi anemia complementation group G 2189
FGFR1OP FGFR1 oncogene partner 11116
FH fumarate hydratase 2271
FIP1L1 FIP1 like 1 (S. cerevisiae) 81608
FUS fusion
Biologics 31.1
inhibitor of
VEGFR-2 (KDR/Flk-1; IC50 FGFR1, HGFR, and
PDGFRβ even at 50 µM levels. Shown to inhibit VEGF-
A-induced VEGFR-2 phosphorylation
Biologics 33.2
= 21.5 nM for FGFR1). It inhibits PDGFR and c-Src kinases only at much
higher concentration (IC50 = 17.6 mM, 19.8 mM, respectively). Blocks the autophosphorylation
of endogenous FGFR1 (IC50 <5 nM) and
Inhibitor Sourcebook 3rd Edition
a human lung
carcinoma expressing oncogenic K-Ras in nude mice. Also inhibits oncogenic signaling
and tumor growth of NIH 3T3 cells transformed with the Ras oncogene at 20 µM.
250 µg
FTI-277 344555
MAPK: Antibodies, Proteins, Kits, siRNA and Reagents
117
(neutralizing)
Anti-FGF-2/basic FGF bFM-2 B H M R RIA WB IH M IgG1κ 500 µg 05-118
Anti-FGFR1 19B2 H R IP WB M IgG1 250 µg 05-149
Anti-Fibroblast Growth Factor basic H IF WB Pur
New Research Tools for Signal Transduction and Life Science Research
ATP-competitive, and reversible inhibitor of FGF and VEGF tyrosine kinase
receptor (IC50 = 21.5 nM for FGFR1).
�41607 2 mg $125
Flt-� Inhibitor A cell-permeable, potent, ATP-competitive, and highly selective